Psyence Biomedical Ltd Stock Math Transform Inverse Tangent Over Price Movement

PBM Stock  USD 2.47  0.01  0.41%   
The math transform module provides an execution environment for Inverse Tangent Over Price Movement transformation and related indicators on Psyence Biomedical. The analysis highlights price transformations that reveal shifts in trend structure and frames technical signals with volatility and risk context.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Psyence Biomedical Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Psyence Biomedical price patterns.

Psyence Biomedical Technical Analysis Modules

Most technical analysis of Psyence Biomedical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Psyence from various momentum indicators to cycle indicators. When you analyze Psyence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Pacific Booker Minerals Inc. engages in the exploration of mineral properties in Canada. This stock section frames Psyence Biomedical within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 0.24. Psyence Biomedical has a market cap of 2.86 M, ROE of -74.29%.

Methodology

Unless otherwise specified, financial data for Psyence Biomedical Ltd is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Psyence (USA Stocks:PBM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Psyence Biomedical Ltd may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Psyence Biomedical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Psyence Biomedical's short interest history, or implied volatility extrapolated from Psyence Biomedical options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Video Games Idea
Video Games
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Cash Cows Idea
Cash Cows
Invested few shares
Momentum Idea
Momentum
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Impulse Idea
Impulse
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares
Software Idea
Software
Invested few shares

More Resources for Psyence Stock Analysis

A structured review of Psyence Biomedical often starts with core financial statements and trend context. Ratio context helps frame profitability, efficiency, and growth trends for Psyence Biomedical Ltd Stock. Highlighted below are reports that provide context for Psyence Biomedical Ltd Stock:
Psyence Biomedical has a market cap of 2.86 M, ROE of -74.29%. Use Your Equity Center to explore allocation context. This includes a position in Psyence Biomedical Ltd inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Analysis related to Psyence Biomedical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
 Earnings Share
-389.98
 Return On Assets
-0.34
 Return On Equity
-0.74
The market value of Psyence Biomedical is measured differently than book value, which reflects Psyence accounting equity. Psyence Biomedical's market capitalization is 2.86 M. A P/B ratio of 0.24 suggests Psyence Biomedical trades near or below book value. Enterprise value stands at 3.4 M. Intrinsic value reflects what Psyence Biomedical's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
Note that Psyence Biomedical's intrinsic value and market price are different measures derived from different inputs. For Psyence Biomedical, key inputs include a P/B ratio of 0.24, and ROE of -74.29%. The quoted price is simply the exchange level where supply meets demand.